Proteogenomic insights into early-onset endometrioid endometrial carcinoma : predictors for fertility-sparing therapy response
© 2024. The Author(s), under exclusive licence to Springer Nature America, Inc..
Endometrial carcinoma remains a public health concern with a growing incidence, particularly in younger women. Preserving fertility is a crucial consideration in the management of early-onset endometrioid endometrial carcinoma (EEEC), particularly in patients under 40 who maintain both reproductive desire and capacity. To illuminate the molecular characteristics of EEEC, we undertook a large-scale multi-omics study of 215 patients with endometrial carcinoma, including 81 with EEEC. We reveal an unexpected association between exposome-related mutational signature and EEEC, characterized by specific CTNNB1 and SIGLEC10 hotspot mutations and disruption of downstream pathways. Interestingly, SIGLEC10Q144K mutation in EEECs resulted in aberrant SIGLEC-10 protein expression and promoted progestin resistance by interacting with estrogen receptor alpha. We also identified potential protein biomarkers for progestin response in fertility-sparing treatment for EEEC. Collectively, our study establishes a proteogenomic resource of EEECs, uncovering the interactions between exposome and genomic susceptibilities that contribute to the development of primary prevention and early detection strategies for EEECs.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - volume:56 |
---|---|
Enthalten in: |
Nature genetics - 56(2024), 4 vom: 02. Apr., Seite 637-651 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Hu, Zhe [VerfasserIn] |
---|
Links: |
---|
Themen: |
---|
Anmerkungen: |
Date Completed 17.04.2024 Date Revised 24.04.2024 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1038/s41588-024-01703-z |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM370550846 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM370550846 | ||
003 | DE-627 | ||
005 | 20240425233435.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240404s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1038/s41588-024-01703-z |2 doi | |
028 | 5 | 2 | |a pubmed24n1386.xml |
035 | |a (DE-627)NLM370550846 | ||
035 | |a (NLM)38565644 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Hu, Zhe |e verfasserin |4 aut | |
245 | 1 | 0 | |a Proteogenomic insights into early-onset endometrioid endometrial carcinoma |b predictors for fertility-sparing therapy response |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 17.04.2024 | ||
500 | |a Date Revised 24.04.2024 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © 2024. The Author(s), under exclusive licence to Springer Nature America, Inc. | ||
520 | |a Endometrial carcinoma remains a public health concern with a growing incidence, particularly in younger women. Preserving fertility is a crucial consideration in the management of early-onset endometrioid endometrial carcinoma (EEEC), particularly in patients under 40 who maintain both reproductive desire and capacity. To illuminate the molecular characteristics of EEEC, we undertook a large-scale multi-omics study of 215 patients with endometrial carcinoma, including 81 with EEEC. We reveal an unexpected association between exposome-related mutational signature and EEEC, characterized by specific CTNNB1 and SIGLEC10 hotspot mutations and disruption of downstream pathways. Interestingly, SIGLEC10Q144K mutation in EEECs resulted in aberrant SIGLEC-10 protein expression and promoted progestin resistance by interacting with estrogen receptor alpha. We also identified potential protein biomarkers for progestin response in fertility-sparing treatment for EEEC. Collectively, our study establishes a proteogenomic resource of EEECs, uncovering the interactions between exposome and genomic susceptibilities that contribute to the development of primary prevention and early detection strategies for EEECs | ||
650 | 4 | |a Journal Article | |
650 | 7 | |a Progestins |2 NLM | |
650 | 7 | |a Antineoplastic Agents, Hormonal |2 NLM | |
700 | 1 | |a Wu, Zimeng |e verfasserin |4 aut | |
700 | 1 | |a Liu, Wei |e verfasserin |4 aut | |
700 | 1 | |a Ning, Yan |e verfasserin |4 aut | |
700 | 1 | |a Liu, Jingbo |e verfasserin |4 aut | |
700 | 1 | |a Ding, Wencheng |e verfasserin |4 aut | |
700 | 1 | |a Fan, Junpeng |e verfasserin |4 aut | |
700 | 1 | |a Cai, Shuyan |e verfasserin |4 aut | |
700 | 1 | |a Li, Qinlan |e verfasserin |4 aut | |
700 | 1 | |a Li, Wenting |e verfasserin |4 aut | |
700 | 1 | |a Yang, Xiaohang |e verfasserin |4 aut | |
700 | 1 | |a Dou, Yingyu |e verfasserin |4 aut | |
700 | 1 | |a Wang, Wei |e verfasserin |4 aut | |
700 | 1 | |a Peng, Wenju |e verfasserin |4 aut | |
700 | 1 | |a Lu, Funian |e verfasserin |4 aut | |
700 | 1 | |a Zhuang, Xucui |e verfasserin |4 aut | |
700 | 1 | |a Qin, Tianyu |e verfasserin |4 aut | |
700 | 1 | |a Kang, Xiaoyan |e verfasserin |4 aut | |
700 | 1 | |a Feng, Chenzhao |e verfasserin |4 aut | |
700 | 1 | |a Xu, Zhiying |e verfasserin |4 aut | |
700 | 1 | |a Lv, Qiaoying |e verfasserin |4 aut | |
700 | 1 | |a Wang, Qian |e verfasserin |4 aut | |
700 | 1 | |a Wang, Chao |e verfasserin |4 aut | |
700 | 1 | |a Wang, Xinyu |e verfasserin |4 aut | |
700 | 1 | |a Wang, Zhiqi |e verfasserin |4 aut | |
700 | 1 | |a Wang, Jianliu |e verfasserin |4 aut | |
700 | 1 | |a Jiang, Jie |e verfasserin |4 aut | |
700 | 1 | |a Wang, Beibei |e verfasserin |4 aut | |
700 | 1 | |a Mills, Gordon B |e verfasserin |4 aut | |
700 | 1 | |a Ma, Ding |e verfasserin |4 aut | |
700 | 1 | |a Gao, Qinglei |e verfasserin |4 aut | |
700 | 1 | |a Li, Kezhen |e verfasserin |4 aut | |
700 | 1 | |a Chen, Gang |e verfasserin |4 aut | |
700 | 1 | |a Chen, Xiaojun |e verfasserin |4 aut | |
700 | 1 | |a Sun, Chaoyang |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Nature genetics |d 1992 |g 56(2024), 4 vom: 02. Apr., Seite 637-651 |w (DE-627)NLM012651230 |x 1546-1718 |7 nnns |
773 | 1 | 8 | |g volume:56 |g year:2024 |g number:4 |g day:02 |g month:04 |g pages:637-651 |
856 | 4 | 0 | |u http://dx.doi.org/10.1038/s41588-024-01703-z |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 56 |j 2024 |e 4 |b 02 |c 04 |h 637-651 |